Close Menu


Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigator Unit Sponsor Date
Evaluation of the Accuracy and Efficiency of Utilizing Virtual-Reality Tools to Diagnose Pulmonary Embolism Grant $10,000.00 Research Jason Lee Medical Imaging Society of Thoracic Radiology 01/2023
Enhancing Early Career Research Ethics to Support Indigenous Research Governance Grant $213,003.00 Research Stephanie Carroll Community Environment & Policy Inter Tribal Council of Arizona, Incorporated 01/2023
Efficacy of novel compounds to activate GPR143 Cooperative Agreement $651.95 Research Brian Mckay Ophthalmology & Vision Science FELIQS Corporation 01/2023
Early in vivo expressed antigens and their role in virulence, immune responses and vaccines for Coccidioidomycosis Contract $315,685.00 Research Kenneth Knox COM Phx Internal Medicine Northern Arizona University 01/2023
Community Settings Approach to Prevention and Education of Diabetes Grant $137,991.00 Research Kelly Palmer UAHS Research American Diabetes Association 01/2023
Construction of the Center for the Center for Advanced Molecular and Immunological Therapies, (CAMI) Building Contract $150,000,000.00 Other Sponsored Activity Michael Dake UAHS Research Office of the Arizona Governor 01/2023
Responsible Adult Marijuana Use Education and Outreach Contract $287,510.00 Instruction Benjamin Brady Comp Pain and Addiction Ctr Arizona Department of Health Services 01/2023
The Use of Povidone-Iodine Sterile Solution To Reduce Periprosthetic Joint Infections: A Superiority Multicentre Randomized Trial Contract $35,698.00 Clinical Trial Joseph Walker COM Phx Orthopedics Center for Innovation and Research Organization, LLC 01/2023
Non-Hodgkin Lymphoma: Epcoritamab in Combination with Anti-Neoplastic Agents Contract $935,073.00 Clinical Trial Abhijeet Kumar Cancer Center Division AbbVie Incorporated 01/2023
Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography, Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Multiple-dose Oral Administratio Contract $405,335.48 Clinical Trial Daniel Combs Pediatrics Idorsia Pharmaceutical (Switzerland) 01/2023
Effect of Continuous Renal Replacement Therapy and Residual Renal Clearance on Cefiderocol Pharmacokinetics in Critically IllAdult Patients Contract $41,209.00 Clinical Trial Nelson Nicolasora COM Phx Internal Medicine Hartford Hospital 01/2023
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy using a Novel Device Contract $1,472,799.00 Clinical Trial Marvin Eng COM Phx Internal Medicine Edwards Lifesciences LLC 01/2023
COVID-19 Neuro Databank/Biobank Contract $11,100.00 Clinical Trial Joyce Lee-Iannotti COM Phx Neurology New York University 01/2023
AbatacepT foR ImmUne Checkpoint Inhibitor Associated Myocarditis (ATRIUM): A Phase 3, Investigator-Initiated, Randomized, Double- Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Contract $205,530.52 Clinical Trial Farouk Mookadam COM Phx Internal Medicine Massachusetts General Hospital 01/2023
A Randomized, Double-Blind, Placebo-Controlled, Phase 2, 6-Month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects with Mild to Moderate Dementia with Lewy Bodi Contract $287,597.00 Clinical Trial Scott Sherman Neurology Synteract HCR 01/2023
A Randomized Phase II Study of Atezolizumab and A Randomized Phase II Study of Atezolizumab and Bevacizumab with Y90 TARE in Patients with Unresectable Hepatocellular Carcinoma (HCC), HCRN GI19-405 Contract $112,864.40 Clinical Trial Gregory Woodhead Cancer Center Division Hoosier Cancer Research Network, Inc. 01/2023
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of Upifitamab Rilsodotin (XMT-1536) as Post-Platnum Maintenance Therapy for Participants with Recurrent, Platinum-Sensitive Contract $217,609.28 Clinical Trial Setsuko Chambers Cancer Center Division GOG Foundation, Inc. 01/2023
A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus Contract $243,322.56 Clinical Trial Mohanad Al-Obaidi Medicine SCYNEXIS, Inc. 01/2023
A Phase 2 Open-label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9) Contract $188,634.56 Clinical Trial Abhijeet Kumar Cancer Center Division Pharmaceutical Research Associates 01/2023
A Phase 1, Multi-center, Open Label First-in-Human Study with ABBV-CLS-579 Alone and in Combination in Subjects with Locally Advanced or Metastatic Tumors Contract $830,548.63 Clinical Trial Jennifer Segar Cancer Center Division AbbVie Incorporated 01/2023
The Single Intravenous Dose Effect of EDGEWISE# in Cats with Hypertrophic Cardiomyopathy Grant $17,695.00 Research Samantha Harris Cellular & Molecular Medicine University of California, Davis 12/2022
Targeting CXCL10 Chemokine Signaling in Breast Cancer Metastasis Grant $153,500.00 Research Suwon Kim COM Phx Basic Medical Sci National Cancer Institute 12/2022
SMARTer Training: A Data-Driven, Collaborative Toolkit to Improve Training and Reporting Outcomes for Contractors and Small Mine Operators Grant $157,936.00 Research Leonard Brown Community Environment & Policy United States Department of Labor 12/2022
Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension Grant $148,589.00 Research Mohamed Ahmed Pediatrics Aqualung Therapeutics, Corp. 12/2022
Plant Exosomes-like Vesicles for Radiomitigator Countermeasures Delivery Grant $147,023.00 Research Frederic Zenhausern COM Phx NanoBioscience & Med Columbia University 12/2022